The sulfated conjugate of biochanin A is a substrate of breast cancer resistant protein (ABCG2)

Biopharmaceutics and Drug Disposition

Volumn 32, Issue 8, 2011, Pages 446-457

  An, Guohua ^a   Morris, Marilyn E ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Biochanin A; Breast cancer resistance protein; Flavonoid; Sulfation; Transport

Indexed keywords

BIOCHANIN A; BIOCHANIN A AGLYCONE; BIOCHANIN A SULFATE; BREAST CANCER RESISTANCE PROTEIN; GENISTEIN; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 2; SULFOTRANSFERASE 1A1; UNCLASSIFIED DRUG;

ANIMAL CELL; APICAL MEMBRANE; ARTICLE; BASOLATERAL MEMBRANE; CELL STRAIN; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG CONJUGATION; DRUG MECHANISM; DRUG POTENTIATION; DRUG TRANSPORT; ENZYME SUBSTRATE; LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY;

ANIMALS; ARYLSULFOTRANSFERASE; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; DOGS; GENISTEIN; HUMANS; ISOENZYMES; MICE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; RNA, MESSENGER; SULFATES; TRANSFECTION;

EID: 80054960683     PISSN: 01422782     EISSN: 1099081X     Source Type: Journal    
DOI: 10.1002/bdd.772     Document Type: Article

References (39)

1. Doyle LA, Yang W, Abruzzo LV, et al. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Nat'l Acad Sci USA 1998; 95: 15665-15670. (Pubitemid 29018757)
2. Hardwick LJ, Velamakanni S, van Veen HW. The emerging pharmacotherapeutic significance of the breast cancer resistance protein (ABCG2). Br J Pharmacol 2007; 151: 163-174. (Pubitemid 46763043)
3. Mao Q, Unadkat JD. Role of the breast cancer resistance protein (ABCG2) in drug transport. AAPS J 2005; 7: E118-E133. (Pubitemid 41554295)
4. Jonker JW, Smit JW, Brinkhuis RF, et al. Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. J Natl Cancer Inst 2000; 92: 1651-1656.
5. Hirano M, Maeda K, Matsushima S, Nozaki Y, Kusuhara H, Sugiyama Y. Involvement of BCRP (ABCG2) in the biliary excretion of pitavastatin. Mol Pharmacol 2005; 68: 800-807. (Pubitemid 41206035)
6. Pavek P, Merino G, Wagenaar E, et al. Human breast cancer resistance protein: interactions with steroid drugs, hormones, the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and transport of cimetidine. J Pharmacol Exp Ther 2005; 312: 144-152. (Pubitemid 40096463)
7. Merino G, Alvarez AI, Pulido MM, Molina AJ, Schinkel AH, Prieto JG. Breast cancer resistance protein (BCRP/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetics, and milk secretion. Drug Metab Dispos 2006; 34: 690-695.
8. Ando T, Kusuhara H, Merino G, Alvarez AI, Schinkel AH, Sugiyama Y. Involvement of breast cancer resistance protein (ABCG2) in the biliary excretion mechanism of fluoroquinolones. Drug Metab Dispos 2007; 35: 1873-1879. (Pubitemid 47481581)
9. Merino G, Jonker JW, Wagenaar E, et al. Transport of anthelmintic benzimidazole drugs by breast cancer resistance protein (BCRP/ABCG2). Drug Metab Dispos 2005; 33: 614-618. (Pubitemid 40593873)
10. Imai Y, Asada S, Tsukahara S, Ishikawa E, Tsuruo T, Sugimoto Y. Breast cancer resistance protein exports sulfated estrogens but not free estrogens. Mol Pharmacol 2003; 64: 610-618. (Pubitemid 37048564)
11. Adachi Y, Suzuki H, Schinkel AH, Sugiyama Y. Role of breast cancer resistance protein (Bcrp1/Abcg2) in the extrusion of glucuronide and sulfate conjugates from enterocytes to intestinal lumen. Mol Pharmacol 2005; 67: 923-928. (Pubitemid 40365339)
12. Gotoh T, Yamada K, Yin H, Ito A, Kataoka T, Dohi K. Chemoprevention of N-nitroso-N-methylureainduced rat mammary carcinogenesis by soy foods or biochanin A. Jpn J Cancer Res 1998; 89: 137-142. (Pubitemid 28143440)
13. Moon YJ, Shin BS, An G, Morris ME. Biochanin A inhibits breast cancer tumor growth in a murine xenograft model. Pharm Res 2008; 25: 2158-2163.
14. Zhang S, Morris ME. Effect of the flavonoids biochanin A and silymarin on the P-glycoproteinmediated transport of digoxin and vinblastine in human intestinal Caco-2 cells. Pharm Res 2003; 20: 1184-1191. (Pubitemid 36951843)
15. Zhang S, Yang X, Morris ME. Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport. Mol Pharmacol 2004; 65: 1208-1216. (Pubitemid 38543491)
16. Moon YJ, Sagawa K, Frederick K, Zhang S, Morris ME. Pharmacokinetics and bioavailability of the isoflavone biochanin A in rats. AAPS J 2006; 8: E433-E442. (Pubitemid 44096604)
17. Sesink AL, Arts IC, de Boer VC, et al. Breast cancer resistance protein (Bcrp1/Abcg2) limits net intestinal uptake of quercetin in rats by facilitating apical efflux of glucuronides. Mol Pharmacol 2005; 67: 1999-2006. (Pubitemid 41007781)
18. Enokizono J, Kusuhara H, Sugiyama Y. Effect of breast cancer resistance protein (Bcrp/Abcg2) on the disposition of phytoestrogens. Mol Pharmacol 2007; 72: 967-975. (Pubitemid 47481419)
19. Ng KH, Lim BG, Wong KP. Sulfate conjugating and transport functions of MDCK distal tubular cells. Kidney Int 2003; 63: 976-986. (Pubitemid 36315575)
20. van Herwaarden AE, Wagenaar E, Karnekamp B, Merino G, Jonker JW, Schinkel AH. Breast cancer resistance protein (Bcrp1/Abcg2) reduces systemic exposure of the dietary carcinogens aflatoxin B1, IQ and Trp-P-1 but also mediates their secretion into breast milk. Carcinogenesis 2006; 27: 123-130. (Pubitemid 43025252)
21. An G, Ruszaj DM, Morris ME. Interference of a sulfate conjugate in quantitative liquid chromatography/tandem mass spectrometry through in-source dissociation. Rapid Commun Mass Spectrom 2010; 24: 1817-1819.
22. Tsoi C, Falany CN, Morgenstern R, Swedmark S. Molecular cloning, expression, and characterization of a canine sulfotransferase that is a human ST1B2 ortholog. Arch Biochem Biophys 2001; 390: 87-92. (Pubitemid 32493573)
23. Tsoi C, Falany CN, Morgenstern R, Swedmark S. Identification of a new subfamily of sulphotransferases: cloning and characterization of canine SULT1D1. Biochem J 2001; 356: 891-897. (Pubitemid 32588463)
24. Tsoi C, Morgenstern R, Swedmark S. Canine sulfotransferase SULT1A1: molecular cloning, expression, and characterization. Arch Biochem Biophys 2002; 401: 125-133. (Pubitemid 34848614)
25. Sugimoto Y, Tsukahara S, Ishikawa E, Mitsuhashi J. Breast cancer resistance protein: molecular target for anticancer drug resistance and pharmacokinetics/pharmacodynamics. Cancer Sci 2005; 96: 457-465. (Pubitemid 41387297)
26. Doyle LA, Ross DD. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene 2003; 22: 7340-7358. (Pubitemid 37487163)
27. Suzuki M, Suzuki H, Sugimoto Y, Sugiyama Y. ABCG2 transports sulfated conjugates of steroids and xenobiotics. J Biol Chem2003; 278: 22644-22649. (Pubitemid 36830322)
28. Chen ZS, Robey RW, Belinsky MG, et al. Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport. Cancer Res 2003; 63: 4048-4054. (Pubitemid 36917926)
29. Imai Y, Tsukahara S, Asada S, Sugimoto Y. Phytoestrogens/flavonoids reverse breast cancer resistance protein/ABCG2-mediated multidrug resistance. Cancer Res 2004; 64: 4346-4352. (Pubitemid 38802442)
30. Goh LB, Spears KJ, Yao D, et al. Endogenous drug transporters in in vitro and in vivo models for the prediction of drug disposition in man. Biochem Pharmacol 2002; 64: 1569-1578. (Pubitemid 35333418)
31. Fardel O, Lecureur V, Guillouzo A. The Pglycoprotein multidrug transporter. Gen Pharmacol 1996; 27: 1283-1291.
32. Giacomini KM, Huang SM, Tweedie DJ, et al. Membrane transporters in drug development. Nat Rev Drug Discov 2010; 9: 215-236.
33. Cui Y, Konig J, Keppler D. Vectorial transport by double-transfected cells expressing the human uptake transporter SLC21A8 and the apical export pump ABCC2. Mol Pharmacol 2001; 60: 934-943. (Pubitemid 33027428)
34. Sasaki M, Suzuki H, Ito K, Abe T, Sugiyama Y. Transcellular transport of organic anions across a double-transfected Madin-Darby canine kidney II cell monolayer expressing both human organic anion-transporting polypeptide (OATP2/ SLC21A6) and multidrug resistance-associated protein 2 (MRP2/ABCC2). J Biol Chem 2002; 277: 6497-6503. (Pubitemid 34968447)
35. Zhang L, Lin G, Chang Q, Zuo Z. Role of intestinal first-pass metabolism of baicalein in its absorption process. Pharm Res 2005; 22: 1050-1058. (Pubitemid 41127062)
36. Mizuma T, Momota R, Haga M, Hayashi M. Factors affecting glucuronidation activity in Caco-2 cells. Drug Metab Pharmacokinet 2004; 19: 130-134.
37. Chen J, Lin H, Hu M. Metabolism of flavonoids via enteric recycling: role of intestinal disposition. J Pharmacol Exp Ther 2003; 304: 1228-1235. (Pubitemid 36254436)
38. Manach C, Donovan JL. Pharmacokinetics and metabolism of dietary flavonoids in humans. Free Radic Res 2004; 38: 771-785. (Pubitemid 39077365)
39. Moon JH, Tsushida T, Nakahara K, Terao J. Identification of quercetin 3-O-beta-D-glucuronide as an antioxidative metabolite in rat plasma after oral administration of quercetin. Free Radic Biol Med 2001; 30: 1274-1285. (Pubitemid 32463938)